Author

Eva Martinez‐Balibrea

Institut Català d'OncologiaORCID 0000-0002-4501-7100Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Carla Vendrell-AyatsiD· 1 shared Cristina BugésiD· 1 shared Cristina Moreta-MoraledaiD· 1 shared Cristina QueraltiD· 1 shared Eva MusuléniD· 1 shared Ferran Grau‐LealiD· 1 shared Jeannine DieschiD· 1 shared Johannes A. ZuberiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Carla Vendrell-AyatsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Loss-of-Function genetic Screen Unveils Synergistic Efficacy of PARG Inhibition with Combined 5-Fluorouracil and Irinotecan Treatment in Colorectal Cancer

Cristina Queralt, Cristina Moreta-Moraleda, Marta Costa, Ferran Grau‐Leal, Jeannine Diesch, Carla Vendrell-Ayats, Eva Musulén, Roni H G Wright, Cristina Bugés, José Luis Manzano, Sara Cabrero‐de las Heras, Johannes A. Zuber, Marcus Buschbeck, Sonia Vanina Forcales, Eva Martinez‐Balibrea

This study identifies PARG as a therapeutic target in colorectal cancer, showing that its inhibition synergizes with 5FU and irinotecan to improve treatment efficacy.

Clinical and Translational Medicine · Dec 1, 2025Peer-reviewedCancer Biology